Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Closer to a Cure: Download Our 2017 Research Year in Review

    Closer to a Cure: Download Our 2017 Research Year in Review

    Read highlights from our 2017 Research Year in Review and download the full report for details on the year's critical programs, initiatives and collaborations that brought us closer to a cure.
    Learn more
  • Inhaled Levodopa Resubmitted to FDA for Review

    Inhaled Levodopa Resubmitted to FDA for Review

    Acorda expects to hear within 74 days whether their inhaled levodopa submission is complete and will be reviewed by the FDA.
    Learn more
  • What We Fund: Proteins, Constipation and Dog Sniffing

    What We Fund: Proteins, Constipation and Dog Sniffing

    Foundation-funded research lays groundwork to deepen understanding of Parkinson's and speed breakthroughs.
    Learn more
  • Parkinson's Tozadenant Trial Discontinued

    Parkinson's Tozadenant Trial Discontinued

    If you or a loved one is part of the trial and have questions or concerns, contact your trial site coordinator or investigator.
    Learn more
  • STAT: 'Michael J. Fox Foundation partners with 23andMe for precision medicine project on Parkinson's'

    STAT: 'Michael J. Fox Foundation partners with 23andMe for precision medicine project on Parkinson's'

    STAT covers the launch of Fox Insight and the collaboration between the Foundation and 23andMe to apply a genetically informed precision medicine approach to Parkinson's research.
    Learn more
  • Broader MJFF-23andMe Collaboration Seeks to Drive Advances through PD Genetics

    Broader MJFF-23andMe Collaboration Seeks to Drive Advances through PD Genetics

    MJFF is partnering with personal genetics company 23andMe in a series of initiatives exploring the use of genetic data to advance PD research.
    Learn more
  • What We Need to Know to Advance Most Promising Parkinson's Therapies

    What We Need to Know to Advance Most Promising Parkinson's Therapies

    In a recent review paper, top Parkinson's experts outline unanswered questions hindering development of treatments against key protein alpha-synuclein.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year